Negative Pressure Wound Therapy Market by Device Type - Global Forecast 2023

According to research report the negative pressure wound therapy market is expected to reach USD 2.72 billion by 2023 from USD 2.01 billion in 2017, at a CAGR of 5.2%. The base year for this study is 2017 and the forecast period is 2018–2023.

Growing prevalence of diabetes, increasing spending on chronic and surgical wounds, government initiatives to prevent SSIs, and high rate of cesarean sections in elderly mothers leading to increasing post-operative use of NPWT devices are some of the factors expected to drive market growth during the forecast period

The negative pressure wound therapy market is segmented by product type, wound type, end user, and region. By product type, the NPWT devices market is categorized into conventional NPWT devices, single-use NPWT devices, and accessories. The conventional segment is expected to account for the largest share of the global NPWT devices market in 2018. This segment is driven by the ability of conventional NPWT systems to manage severe wound exudates. However, high costs and the growing adoption of disposable NPWT devices are restraining market growth to a certain extent.

Liquid Biopsy Market – Size, Share, Trends | Global Forecast 2022

According to the new market research report "Liquid Biopsy Market" worth USD 2,047.9 Million by 2022, at a CAGR of 23.4%.

The key factors driving the growth of this market include increasing prevalence of cancer, increasing preference for noninvasive procedures, initiatives undertaken by government and global health organizations, technological advancement to augment market revenues, rising emphasis on personalized medicine, and availability of funding for liquid biopsy R&D.

On the basis of product, the liquid biopsy market is broadly segmented into assays kits, instruments, and services. In 2017, the assay kits segment is expected to account for the largest share of this market. The increase in basic research and commercial applications of liquid biopsy, increase in demand for liquid biopsy tests, and the need for reliable and specific assays are expected to drive the market growth.

Based on circulating biomarkers the market is categorized into circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers. In 2017, the circulating tumor cells segment is expected to account for the largest share of the liquid biopsy market. The ability for early assessment of patient prognosis and also providing valuable information to make a clinical decision is driving the growth of the CTC segment in the liquid biopsy market.

By clinical application, the therapy selection segment is expected to account fors the largest market share in 2017

By application, the cancer segment is expected to account for the largest market share in 2017

By end user, the reference laboratories segment is expected to account for the largest market share in 2017

Market PlayersThe key players in the global liquid biopsy market are QIAGEN N.V. (Netherlands), Roche Diagnostics (US), Bio-Rad Laboratories Inc. (US), Myriad Genetics, Inc. (US), Menarini Silicon Biosystems (Italy), Genomic Health, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Biocept, Inc. (US), Trovagene, Inc. (US), Guardant Health, Inc. (US), RainDance Technologies, Inc. (US), and MDx Health SA (US).

Strategies Adopted by the Major Players in this Digital PCR Market

According to research report the Digital PCR Market is expected to grow from USD 3.47 billion in 2017 to USD 5.31 billion by 2022, at a CAGR of 8.9% during the forecast period.

Product Launches: Key Strategy Adopted by the Major Players in this Market

New product launches and approvals are the key growth strategies adopted by major players to strengthen their position in the global Digital PCR Market. Moreover, strategies such as partnerships, collaborations, and agreements; as well as mergers and acquisitions were also adopted by several market players to strengthen their market position, expand their R&D capabilities, and geographic presence in the global Digital PCR Market.

The key players in the Digital PCR Market include Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Fluidigm Corporation (US), Danaher Corporation (US), Abbott Laboratories (US), Merck KGaA (Germany), Promega Corporation (US), Becton, Dickinson and Company (US), Meridian Bioscience, Inc. (US), and Analytik Jena AG (Germany), among others.

HIV Diagnosis Market Worth $3.88 Billion by 2021

According to a new market research report “HIV Diagnosis Market by Test Type (Antibody (ELISA, Rapid, Western Blot), Viral Load, CD4 Count, Early Infant, Viral Identification), Product (Assay, Kit, Reagent, Instrument, Software, Services), End User (Hospitals) – Global Forecast to 2021” published by MarketsandMarkets, the market is projected to reach USD 3.88 Billion by 2021 from USD 2.35 Billion in 2016, at a CAGR of 10.5% from 2016 to 2021.

The report provides a detailed overview of the major drivers, restraints, opportunities, trends, and strategies impacting the HIV diagnosis market along with the estimates and forecasts of the revenue and market share analysis. The major factors driving the growth of this market are increasing prevalence of HIV/AIDS worldwide, increasing number of blood transfusions and blood donations, advancements and benefits offered by point-of-care instruments & kits, and increasing awareness about HIV/AIDS and increasing government initiatives.

Ask for PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=66008285

The report segments this market based on product, test type, end user, and region. On the basis of product, the market is segmented into consumables (assay, kits, reagents, and other consumables), instruments, and software and services. In 2016, the consumables segment is expected to account for the largest share of the market. The frequent and repetitive purchase of consumables by laboratories and hospitals, growing prevalence of HIV/AIDS, and increasing initiatives from governments to fight HIV/AIDS are some of the major factors driving the consumables market.

On the basis of test type, the market is segmented into antibody tests, viral load tests, CD4 count tests, tests for early infant diagnosis, and tests for viral identification. The antibody tests segment is further categorized into HIV-1 screening tests, HIV-1 confirmatory tests, and HIV-2 and group O diagnostic tests. The viral load tests segment is expected to grow at the highest CAGR during the forecast period due to increasing awareness about early detection of HIV/AIDS and high accuracy of these tests.

On the basis of end user, the HIV diagnosis market is segmented into diagnostic laboratories, hospitals, blood banks, home care settings, and others (gene banks, cell banks, biotechnology and pharmaceutical companies, and academic research institutes). The diagnostic laboratories segment is expected to account for the largest share of HIV diagnosis market in 2016. Increasing awareness about HIV/AIDS and advancements in PoC instruments and consumables are major drivers for this end-user segment.

On the basis of region, the market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2016, North America is expected to account for the largest share of the market. Growth in this region is mainly driven by the high prevalence of HIV/AIDS, increasing number of blood transfusion and blood donations, increasing awareness about HIV/AIDS and increasing government initiatives, and technological advancements test and better offering of PoC settings.

Key players in the HIV Diagnosis Market include Siemens AG (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (U.S), Danaher Corporation (U.S.), Thermo-Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Hologic, Inc. (U.S.), Alere Inc. (U.S.), and Bio-Rad Laboratories (U.S.).

Key Strategies Adopted by Market Players of Global Thrombectomy Devices Market

According to a new market research report “Thrombectomy Devices Market by Type (Hydrodynamic, Ultrasound, Aspiration, Mechanical Thrombectomy), Application (Cardiovascular, Peripheral, Neurovascular), End User (Hospitals, Surgical Centers, Ambulatory, Academia, CROs) – Global Forecasts to 2022” published by MarketsandMarkets™, the market is expected to reach USD 1.45 Billion by 2022 growing at a CAGR of 6.7%.

This report studies the Thrombectomy Devices Market over the forecast period of 2017 to 2022. On the basis of type, the global Thrombectomy Devices Market is segmented into aspiration, mechanical/fragmentation, rheolytic/hydrodynamic, and ultrasonic thrombectomy devices. The mechanical/fragmentation thrombectomy devices segment accounted for the largest share of the market in 2016. This large share is attributed to the ongoing commercialization of mechanical thrombectomy products, favorable reimbursement scenario, established therapeutic efficacy, growing market demand for stent retrievers among medical professionals, and rising end-user preference for minimally invasive thrombectomy procedures.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=222966801

The key players focused on various strategies such as product launches and enhancements; agreements and collaborations; strategic acquisitions; and expansions to increase their shares in the global thrombectomy devices market. Product launches & enhancements is the strategy adopted by major industry players to achieve the desired market growth during 2013-2017. This strategy was adopted by Stryker Corporation (U.S.), Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), Johnson & Johnson (U.S.), Terumo Corporation (Japan), Penumbra, Inc. (U.S.), Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), and Teleflex Incorporated (U.S.). Apart from product launches and enhancements, many prominent players also adopted agreements and collaborations as their key growth strategy to strengthen their market presence, enhance their R&D capabilities, and to expand their distribution networks to generate additional demand by sensitizing end users through an increase in availability of thrombectomy devices.

Stryker Corporation held the leading position in the market in 2016. The company offers its thrombectomy devices through the Neurotechnology & Spine segment. The company has a strong presence in North America, Europe, the Middle East, Africa, Asia-Pacific and other countries. The company has more than 30 manufacturing facilities in countries such as the U.S., China, Turkey, Germany, Ireland, Switzerland, and France. It primarily focuses on growth strategies such as product development & commercialization, acquisitions, and market expansions. The market has witnessed several product launches & commercialization, expansions, and acquisitions by Stryker Corporation (U.S.) in the last three years.

Medtronic plc is one of the prominent players in the market, in 2016. The company has a strong foothold in the market with a broad range of thrombectomy products. The company has a strong geographic presence across Asia-Pacific, Eastern Europe, Latin America, the Middle East & Africa, Central Asia, Western Europe, South Asia, and North America. To strengthen its current position and to gain a larger share in the market, the company aggressively focuses on growth strategies such as acquisitions and market expansions. During 2012–2016, the company established its training and research facility—Covidien Center of Innovation Brazil—in Brazil and its R&D, training, and education center—Covidien Center of Innovation Korea—in South Korea to enhance its R&D capabilities and expand its product portfolio and market presence in the market. The company also focuses on product commercialization as its business strategy. It commercialized thrombectomy devices such as the Solitaire stent retriever device in 2016 and Solitaire revascularization device in 2012.

Sinus Dilation Devices Market International Players and Business Insights

The global sinus dilation devices market is expected to reach USD 2.78 billion by 2023 from USD 1.80 billion in 2018, at a CAGR of 9.1%. The growth of this market is mainly driven by the high prevalence of chronic sinusitis, growing preference for minimally invasive procedures, benefits of balloon sinuplasty/sinus dilation over conventional sinus surgeries, and favorable reimbursement scenario for sinus procedures in developed countries.

Agreements, collaborations, partnerships, and expansions are some of the major growth strategies followed by key players between 2015 and 2018. Key players in the sinus dilation devices market include Entellus Medical Inc. (Subsidiary of Stryker) (US), Acclarent Inc. (Subsidiary of Johnson & Johnson) (US), Medtronic plc (Ireland), Smith & Nephew plc (UK), Intersect ENT Inc. (US), and Olympus Corporation (Japan). Other players in the market include Meril Life Sciences Pvt Ltd. (India), SinuSys Corporation (US), InAccel (India), Jilin Coronado Medical Ltd. (China), and Creganna Medical (Ireland).

Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810

In 2017, Acclarent (US) was the leading player in the global sinus dilation devices market. The company’s leading position is attributed to its wide presence in key markets such as the US, Europe, APAC, and the Middle East. The company has a vast customer base spanning more than 160 countries and operates in over 370 locations across the globe. The company has a vast product portfolio and specializes in minimally invasive ENT surgery products. It offers a broad range of devices such as balloon sinuplasty systems, ethmoid punch, and airway dilation systems. To maintain its position in the market, Acclarent spends exhaustively on research and development. In 2016, the company spent 12.7% of its revenue (USD 9.10 billion), which was increased to 13.7% of its revenue (USD 10.5 Billion) in 2017.

In 2017, Entellus (US) held the second position in the sinus dilation devices market. This can be attributed to the strong brand name in high-growth geographies and an increasing presence in emerging markets. The company is present in key regions such as North America and focuses on indirect distribution in 15 countries in Europe. The company has a broad product portfolio in the sinus dilation devices market. It also has an extensive sales force in the US to ensure an increased penetration of its product line in the country. The company also focuses on product launches and product approvals to increase its customer base. For example, in November 2015, the company received FDA Clearance for XprESS Multi-Sinus Dilation System in pediatric patients.

Veterinary Dental Equipment Market Size, Share, Trends and Forecast 2023

According to the new market research report  “Veterinary Dental Market by Product (Work Station, X-Ray, Laser, Ultrasonic Scaler, Micromotor, Electrosurgical Unit, Handpieces, Forceps, Curettes, Retractors, Probe, Scalers), Animal, End User, and Region – Global Forecast to 2023″, published by MarketsandMarkets™, the Veterinary Dental Equipment Market is projected to reach USD 490 million by 2023 from USD 329 million in 2018, at a CAGR of 8.3% during the forecast period.

Growth in the global companion animal population, the rising incidence of veterinary dental problems, and growth in the number of veterinary practitioners and income levels in developed economies during the forecast period are the primary drivers for the Veterinary Dental Equipment Market during the forecast period.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155083837

“The dental equipment segment to account for the largest market share in 2018”

On the basis of product, the Veterinary Dental Equipment Market is segmented into equipment, hand instruments, consumables, and adjuvants. The dental equipment segment is expected to account for the largest share of the Veterinary Dental Equipment Market in 2018. The high cost of dental equipment and the rising income level of veterinarians, resulting in the higher adoption of dental equipment, are major factors responsible for the large share of this segment.

“The small companion animals Segment is expected to dominate the Veterinary Dental Equipment Market during the forecast period of 2018 to 2023”

North America is expected to account for the largest share of the Veterinary Dental Equipment Market in 2018, followed by Europe and the Asia Pacific. The growing number of veterinary practices, increasing number of companion animals, and rising companion animal healthcare expenditure are some of the key factors driving the growth of the Veterinary Dental Equipment Market in North America.

Upcoming Industry Applications for Nurse Call Systems Market

Emergency medical alarms and wanderer control applications drive the growth of nurse call systems market

Emergency Medical Alarms

Emergency medical alarm devices are essential for providing safe care in critical care settings, including emergency rooms, intensive care units, and critical care units. Medical alarms when used properly, provide crucial information to clinicians which can be used to make diagnostic and treatment decisions. Various devices that help in triggering medical alarms include pendants worn around the neck, small devices worn on the belt, wristbands, installed motion detectors, radar-based detectors in a room, and smart phones. Personal emergency response systems and ambulatory auto alert systems are some types of emergency medical alarms used in healthcare facilities. The purpose of these systems is not only to secure vulnerable individuals, such as senior citizen, in case of medical emergencies such as heart attacks, sudden falls, and memory loss due to dementia and Alzheimer’s but also to help senior living facilities and assisted living facilities take appropriate and timely measures in case of medical emergencies.

Wanderer Control

Wanderer control solutions monitor the movement of residents under observation; if a resident moves into a restricted area or moves outside a specified safe area while wearing a wireless tag, a door controller detects the tag and sends a wireless signal to PC systems. Post this, an alarm is displayed on the PC system, remote event monitors, and master stations. Depending upon the configuration of these solutions, PC systems and remote event monitors can also display the resident’s name, photo, and other custom information. Wanderer control gives residents the freedom to move within a facility, while preventing them from entering into restricted areas. In a facility, each exit can be monitored based on security needs, traffic, and resident population. Using wanderer control solutions, end user facilities can monitor residents, signal alerts automatically, and eliminate wandering as doors get locked automatically before patients wander off.

Global Contrast Media Injectors Market - Which segment to grow at the highest CAGR?

The global contrast media injectors market is expected to reach USD 636.1 million by 2021. Factors such as increasing number of approvals for contrast agents, increasing number of public and private diagnostic centers, technological advancements in the contrast media injector arena and the increased focus of market players in the injector technology provide high growth opportunities for players in the global contrast media injectors market.

Interventional cardiology segment to grow at the highest CAGR during the forecast period

On the basis of application, the global contrast media injectors market is segmented into interventional radiology, and interventional cardiology applications. The radiology segment is expected to account for the largest share of the global contrast media injectors market whereas the interventional cardiology segment is expected to grow at the highest CAGR. The growth of the market can be attributed to the high global CVD burden. According to the World Heart Federation (WHF), by 2030, nearly 23.6 million people are predicted to die worldwide from CVD. This is leading to an increase in the demand for cardiac intervention procedures and coronary diagnostic procedures.

Key players in the global contrast injectors market include Bracco Imaging S.p.A. (Italy), Bayer HealthCare (Germany), Guerbet Group (France), Medtron AG (Germany), ulrich GmbH & Co. KG (Germany), GE Healthcare (U.S.), AngioDynamics (U.S.), Nemoto Kyorindo Co., Ltd. (Japan), Sino Medical- Device Technology Co., Ltd. (China), VIVID IMAGING (China), and Apollo RT Co., Ltd. (China).

Wearable Medical Devices Market - Increasing use of mobile technology is one of the major growth factor

The global wearable medical device market, in terms of value, is projected to reach USD 12.14 billion by 2021 from USD 5.31 billion in 2016, at a CAGR of 18.0% during the forecast period. The wearable medical services market is segmented based on type, distribution channel, end use, application, and regions. 

Increasing use of mobile technology is one of the major factors driving the growth of the wearable medical devices market. With the development of devices such as smartphones connected with various medical apps, wearable wrist band monitors, and cuffless blood pressure monitors, the monitoring of health conditions has become more efficient and effective. Moreover, these devices enable sharing of a patient’s medical records with doctors over a period of time, which helps in the proper diagnosis and treatment of diseases.

The wearable medical devices market is expected to witness significant growth in the coming years, due to the increasing adoption of these devices in various applications, such as diagnostic and monitoring, therapeutics, and health and fitness. Rising health concerns among people and the growing focus on monitoring day-to-day variations in health conditions are the major factors driving the uptake of wearable medical devices among end users. 

North America is expected to dominate the market in 2016, with the U.S. accounting for a major share. However, Asia is expected to grow at the highest CAGR during the forecast period, The high growth in this market is attributed to of developed infrastructure and the focus on technological advancement and development of interconnected and highly advanced healthcare apps and compatible devices.

What are the upcoming applications for cancer immunotherapy?

Increase in adoption of immunotherapy over other treatment options is driving the growth of the cancer immunotherapy market

The treatment options for cancer, such as chemotherapies and radiation therapy, although have more side effects, are more widely used as compared to immunotherapies. The former are all based on destroying cancer cells by irradiation, chemotherapy, or surgery. While they can effectively kill or remove cancer cells, the use of these treatments is often limited because they tend to destroy healthy cells in large numbers as well. As immunotherapies involve the mechanism of enhancing the body’s own immunity using man-made proteins such as monoclonal antibodies, they are accepted worldwide over other treatment options.

While immunotherapy has shown significant promise in the area of cancer treatment, its high cost has served to limit overall patient access. This poses a significant financial burden on low- and middle-income cancer patients. This is restricting the cancer immunotherapy market from growing at its full potential.

Some of the key players in this market are Amgen Inc. (U.S.) F. Hoffmann-La Roche Ltd (Switzerland) Bristol-Myers Squibb Company (U.S.) Merck & Co., Inc. (U.S.), Seattle Genetics Inc. (U.S.), Celgene Corporation (U.S.), Eli Lilly and Company (U.S.).

According to research report the global cancer immunotherapy market is expected to reach USD 119.39 Billion by 2021 from USD 61.97 Billion in 2016, at a CAGR of 14.0% from 2016 to 2021.

Get Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=197577894 

Who dominate the global Accountable Care Solution Market? Know the top players strategies

In the light of the escalating healthcare costs, currently, the global healthcare industry is increasingly looking forward to reduce the administrative and clinical expenditure by implementing various healthcare IT tools in their organizations. With the growing demand for simplified data-sharing among various stakeholders in the healthcare industry, majority of the software vendors are focusing on incorporating greater degree of interoperability in their product portfolio. This is one of the key factors driving innovation in the global accountable care solution market. Healthcare provider solutions (such as EHR/EMR, healthcare analytics, RCM, PHM, HIE and CDSS) and payer solutions (such as claims management solutions, payment management solutions) are at the focus of such innovations from vendors in the accountable care solutions market.

Although, the global Accountable Care Solution Market is highly fragmented in nature with the presence of a number of small and medium-sized vendors operating at local and regional levels, Cerner Corporation (U.S.), Epic Systems Corporation (U.S.), McKesson Corporation (U.S.), and Allscripts Healthcare Solutions, Inc. are some of the leaders in the healthcare provider solutions market. Whereas, IBM Corporation (U.S.), UnitedHealth Group (U.S.), Aetna, Inc. (U.S.) are leaders in the healthcare payer solutions market. While product innovation remains at the center of the strategic growth initiatives pursued by a majority of the key vendors in the global accountable care solutions market, players are also focusing on increasing their presence in the high-growth markets through the mode of expansions, strategic marketing and distribution agreements, and acquisitions.

Cerner Corporation’s leading position in the Accountable Care Solution Market is mainly attributed to its broad product portfolio with major focus on clinical healthcare IT solutions. While nearly 89% of the company’s revenue is attributed to its operations in the North American market, currently, the company is focusing to strengthen its presence in the international markets as well, through the mode of expansions and agreements. For instance, in February 2015, Cerner Corporation acquired Siemens’s health information technology business unit for ~USD 1.3 billion. This acquisition will strengthen Cerner’s client base in the global market and will expand its reach in European countries such as Germany, Austria, Spain, Sweden, and Norway.

Epic Systems Corporation offers a wide range of both provider and payer accountable care solutions, which has enabled the company to achieve a leading position in the accountable care solutions market. However, due to its major presence in the U.S, the company generates a majority of its revenue from North American operations. Similarly, Mckesson Corporation (U.S.) and Allscripts Healthcare Solutions, Inc. are the leading providers of EHR systems and related solutions in the U.S.

Some other leading players in the global Accountable Care Solution Market include IBM Corporation (U.S.), UnitedHealth Group (U.S.), Aetna, Inc. (U.S.), eClinicalWorks, Inc. (U.S.). These companies have well-established sales and distribution networks. They also make significant investments in R&D activities to add innovative technologies and products to their portfolio. With a strong portfolio of healthcare IT solutions and ceaseless efforts to develop innovative products, these companies are likely to maintain their strong position in the market in the coming years as well. 

Industry players adopted the strategy of agreements, collaborations, and partnerships, product launches, and mergers and acquisitions as major growth strategies to achieve growth in the global accountable care solutions market. In order to strengthen their market position and customer base, companies adopted new product launches as a key growth strategy. This strategy also helped companies to garner larger market shares and strengthen their customer base.

According to research report accountable care solutions market is expected to grow from USD 8.75 billion in 2016 to USD 18.85 billion by 2021 at a CAGR of 16.6%.

Download Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=229274233